CoChat

Pyrvinium pamoate inhibits cell proliferation through ROS-mediated AKT-dependent signaling pathway in colorectal cancer

Open access

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

The use of the anthelmintic drug pyrvinium pamoate (PP) in cancer therapy has been extensively investigated in the last decade. PP has been shown to have an inhibitory effect in colorectal cancer (CRC), but the underlying mechanism remains elusive. We aimed to investigate the antitumor activity and mechanisms of PP in CRC. In the present study, we used CCK-8 assays, colony formation assays, and western blotting to reveal that PP effectively suppressed CRC cell proliferation and the AKT-dependent signaling pathway in a concentration-dependent and time-dependent manner. Flow cytometric analysis and fluorescence microscopy demonstrated that PP increased intracellular reactive oxygen species (ROS) accumulation. We found that the inhibitory effect of PP on cell proliferation and AKT protein expression induced by PP could be partially reversed by N-acetyl-l-cysteine (NAC), an ROS scavenger. In addition, the results also demonstrated that PP inhibited cell migration by modulating epithelial-to-mesenchymal transition (EMT)-related proteins, including E-cadherin and vimentin. In conclusion, our data suggested that PP effectively inhibited cell proliferation through the ROS-mediated AKT-dependent signaling pathway in CRC, further providing evidence for the use of PP as an antitumor agent.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12032-021-01472-3

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Sensitivity of different colorectal cancer cells and normal human colon epithelial cells to pyrvinium. Three CRC cell lines (HCT116, RKO, and HT29) and one normal human colon epithelial cell line (Ncm460) were treated for 72 h with the indicated concentrations of pyrvinium. The means ± standard deviation are shown
Fig. 1 Sensitivity of different colorectal cancer cells and normal human colon epithelial cells to pyrvinium. Three CRC cell lines (HCT116, RKO, and HT29) and one normal human colon epithelial cell line (Ncm460) were treated for 72 h with the indicated concentrations of pyrvinium. The means ± standard deviation are shownCC BY · PubMed Central
Fig. 2 Pyrvinium inhibits cell proliferation in a concentration-dependent manner. a The CCK-8 assay was used to measure cell viability after treatment with pyrvinium. b Cells were cultured for 14 days with pyrvinium, and stained with 0.1% crystal violet. c The protein expression of Ki67 in HCT116 cells was evaluated by Western blotting
Fig. 2 Pyrvinium inhibits cell proliferation in a concentration-dependent manner. a The CCK-8 assay was used to measure cell viability after treatment with pyrvinium. b Cells were cultured for 14 days with pyrvinium, and stained with 0.1% crystal violet. c The protein expression of Ki67 in HCT116 cells was evaluated by Western blottingCC BY · PubMed Central
Fig. 3 Effect of pyrvinium on ROS in colorectal cancer cells. The level of intracellular ROS was measured by flow cytometry (a) and fluorescence microscopy (b) after treatment with different concentrations of pyrvinium. c After treatment with PP for 2, 4, 6, 8 h, the level of intracellular ROS was measured by flow cytometry **P < 0.01, ***P < 0.001
Fig. 3 Effect of pyrvinium on ROS in colorectal cancer cells. The level of intracellular ROS was measured by flow cytometry (a) and fluorescence microscopy (b) after treatment with different concentrations of pyrvinium. c After treatment with PP for 2, 4, 6, 8 h, the level of intracellular ROS was measured by flow cytometry **P < 0.01, ***P < 0.001CC BY · PubMed Central
Fig. 4 NAC reverses the inhibitory effects of pyrvinium. a For Western blot analysis, HCT116 cells were treated with increasing concentrations of pyrvinium for 24 h. Cells were treated with pyrvinium (0.50 μM) in the absence and presence of NAC (5 mM), and then intracellular ROS (b), cell viability (c), and the expression of AKT and Ki67 in HCT116 cells (d) were measured. **P < 0.01, ***P < 0.001
Fig. 4 NAC reverses the inhibitory effects of pyrvinium. a For Western blot analysis, HCT116 cells were treated with increasing concentrations of pyrvinium for 24 h. Cells were treated with pyrvinium (0.50 μM) in the absence and presence of NAC (5 mM), and then intracellular ROS (b), cell viability (c), and the expression of AKT and Ki67 in HCT116 cells (d) were measured. **P < 0.01, ***P < 0.001CC BY · PubMed Central
Fig. 5 Pyrvinium pamoate inhibits the migration of cells. a The migration of cells was observed under an inverted microscope. **P < 0.01, ***P < 0.001. b RKO cells were treated with DMSO and different concentrations of pyrvinium. Cells were monitored by microscopy and digital images were captured. c The expression of E-cadherin and Vimentin in HCT116 cells was evaluated by Western blotting
Fig. 5 Pyrvinium pamoate inhibits the migration of cells. a The migration of cells was observed under an inverted microscope. **P < 0.01, ***P < 0.001. b RKO cells were treated with DMSO and different concentrations of pyrvinium. Cells were monitored by microscopy and digital images were captured. c The expression of E-cadherin and Vimentin in HCT116 cells was evaluated by Western blottingCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 21

Metadata

Authors
Zheng, W., Hu, J., Lv, Y., Bai, B., Shan, L., Chen, K., Dai, S., & Zhu, H.
Affiliations
Sir Run Run Shaw Hospital (CN)
Corresponding author
Zhu, Hongbo
Venue
Medical Oncology
Published
2021-02
Volume
38
Issue
2
Pages
21-21
ISSN
  • 1357-0560 (ISSN-L)
  • 1559-131X
OpenAlex
W3127161950
Cited by
21
References
52
Citations by year
2026: 4 · 2025: 8 · 2024: 5 · 2022: 4
FWCI
0.71
Type
journal article
Language
en
Open access
Licence
Locations
  • Medical Oncology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81272681)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
pyrvinium pamoate, colorectal cancer, reactive oxygen species, Akt signaling, cell proliferation inhibition, anthelmintic repurposing, N-acetylcysteine, epithelial-mesenchymal transition, E-cadherin, vimentin, cell migration
MeSH terms
Cell Movement, Cell Survival, Humans, Pyrvinium Compounds, Colorectal Neoplasms, Signal Transduction, Reactive Oxygen Species, Cell Line, Tumor, Cell Proliferation, Proto-Oncogene Proteins c-akt, Epithelial-Mesenchymal Transition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pyrvinium pamoate inhibits cell proliferation through ROS-mediated AKT-dependent signaling pathway in colorectal cancer. https://app.cochat.ai/papers/10.1007/s12032-021-01472-3
The paper
Zheng, W., Hu, J., Lv, Y., Bai, B., Shan, L., Chen, K., Dai, S., & Zhu, H. (2021). Pyrvinium pamoate inhibits cell proliferation through ROS-mediated AKT-dependent signaling pathway in colorectal cancer. Medical Oncology. https://doi.org/10.1007/s12032-021-01472-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.